Government scientists say they've found a human cell surface molecule involved with the Kaposi's sarcoma herpes virus.
The researchers at the National Institute of Allergy and Infectious Disease say the molecule xCT is a major gateway the herpes virus uses to enter human cells and might also play a role in the development of Kaposi's sarcoma and other syndromes associated with the virus.
The natural function of xCT is to transport molecules necessary for protecting against stress into cells. When cells are stressed, they express more xCT. Such stress can be caused by KSHV itself and that, scientists say, suggests the virus may cause itself to be more effective.
"Understanding the mechanisms of cell entry of Kaposi's sarcoma herpes virus is a landmark achievement in and of itself," said NIAID Director Dr. Anthony Fauci. "But the connection between the virus and expression of its own receptor on a cell is even more provocative because it might change the way we think about (Kaposi's sarcoma herpes virus-associated) diseases and their treatment."
The research appears in the journal Science.
Copyright 2006 by United Press International
Related stories:
Newly discovered virus linked to deadly skin cancer
A new strategy to hunt for human viruses described in this week’s issue of the journal
Science by the husband-and-wife team who found the cause of Kaposi’s sarcoma has revealed a previously unknown virus strongly associated with another rare but deadly skin cancer called Merkel cell carcinoma.
Study proposes new theory of how viruses may contribute to cancer
A new study suggests that viruses may contribute to cancer by causing excessive death to normal cells while promoting the growth of surviving cells with cancerous traits. Viruses may act as forces of natural selection by wiping out normal cells that support the replication of viruses and leaving behind those cells that have acquired defects in their circuitry.
An AIDS-related virus reveals more ways to cause cancer
Researchers at the University of Pennsylvania School of Medicine have shed new light on how Kaposi’s Sarcoma-associated Herpes Virus (KSHV) subverts normal cell machinery to cause cancer. A KSHV protein called latency-associated nuclear antigen, LANA for short, helps the virus hide out from the immune system in infected cells. When LANA takes the place of other proteins that control cell growth, it can cause uncontrolled cell replication.
DNA damage response confers a barrier for viral tumorigenesis
Kaposi’s sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi’s sarcoma (KS). KSHV infection is endemic in sub-Saharan Africa where KS is nowadays the most common malignancy, due to widespread infection with KSHV and human immunodeficiency virus (HIV). Importantly, KS also occurs in HIV-negative individuals. Researchers at the University of Helsinki, Finland, have discovered that activation of the DNA damage response in the early stages of KS development functions as an anti-cancer barrier also in virus induced malignancies.
Pregnancy may slow -- not accelerate -- progression to AIDS
A new study may help put to rest fears that pregnancy accelerates progression to full-blown AIDS in women with HIV receiving antiretroviral therapy. The study, published in the October 1st issue of the Journal of Infectious Diseases and now available online, revealed that pregnancy may, in fact, slow disease progression in these women.
Penn researchers discover new mechanism for viral replication
Researchers at the University of Pennsylvania School of Medicine have identified a new strategy that Kaposi’s Sarcoma Associated Herpesvirus (KSHV) uses to dupe infected cells into replicating its viral genome. This allows the virus to remain virtually undetected by the body’s immune system. Previous work suggested KSHV needed viral proteins to initiate replication, but this is the first study to directly show that a section of viral DNA can independently draw upon proteins within a host cell to promote its own replication. The study was published in the August issue of
Cell Host and Microbe.
Cancer risk in HIV, transplant patients
HIV/AIDS and kidney transplant patients are at much greater risk of contracting 20 different types of cancer than the general population, according to a land mark paper in
The Lancet.
Scientists identify cancer virus' genetic targets
University of Florida researchers have identified specific human genes targeted by a virus believed to cause Kaposi’s sarcoma, a rare form of cancer associated with AIDS and with organ transplants that causes patches of red or purple tissue to grow under people’s skin.